Pura Vida Investments’s Boston Scientific BSX Stock Holding History

Pura Vida Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-125,000	Closed	-$6.6M	–	57
2023 Q3	$6.6M	Buy	125,000 +25,700	+26%	+$1.35M	1.25%	30
2023 Q2	$5.37M	Buy	+99,300	New	+$5.19M	0.71%	39
2022 Q2	–	Sell	-400,000	Closed	-$17.7M	–	218
2022 Q1	$17.7M	Buy	+400,000	New	+$17.3M	0.57%	43
2018 Q3	–	Sell	-200,000	Closed	-$6.54M	–	110
2018 Q2	$6.54M	Buy	+200,000	New	+$6.03M	2.62%	9
2017 Q1	–	Sell	-200,000	Closed	-$4.33M	–	82
2016 Q4	$4.33M	Buy	+200,000	New	+$4.36M	1.59%	26

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pura Vida Investments's BSX Position: Q4 2022 in Review

Pura Vida Investments sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 48,635 shares — an estimated $1.88M sold.

Pura Vida Investments first reported a position in BSX in Q4 2014 and held it in 22 quarters. The position peaked at $11.7M in Q2 2017. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Pura Vida Investments reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 48,635 Boston Scientific shares in Q4 2022, an estimated $1.88M.
Pura Vida Investments first reported a position in Boston Scientific in Q4 2014 and held it in 22 quarters.
Pura Vida Investments's Boston Scientific position peaked at $11.7M in Q2 2017.
929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.